Since the removal of urokinase (Abbokinase, Abbott Labs, Abbott Park, IL) from the US market, either recombinant tissue plasminogen activator (rt-PA) (Alteplase, Genentech, South San Francisco ...

Recombinant human prourokinase is noninferior to alteplase for acute ischemic stroke outcomes and is associated with decreased rates of symptomatic intracranial hemorrhage and major bleeding ...

If you're heading out on a flight from Tampa International Airport, a massive winter storm to the north may delay your flight or see it canceled on Friday. A winter storm warning extends from ...

SOUTH SAN FRANCISCO, Calif., December 19, 2024--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today results from the Phase IIb PADOVA study ...

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced that its phase IIb study of Prasinezumab in early-stage Parkinson's disease missed the primary endpoint, but data suggested ...

Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...

In 2025, the government will issue additional standards to be published in categories such as green hydrogen production, storage and transportation, its various applications such as in aviation ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...

Recent studies suggest that the use of adjunctive intraarterial alteplase after mechanical thrombectomy (MT) may improve outcomes; however, there are limited data on the use of intraarterial ...

San Francisco, California–based Genentech, has potent antitumor activity. More than half the patients with advanced and inoperable skin cancer treated with GDC-0449 responded to treatment (New Engl.